CompletedPhase 1ketamine
Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine
Sponsored by University Hospital, Basel, Switzerland
NCT ID
NCT00847418
Start Date
2009-02
Est. Completion
2009-10
About This Study
The purpose of this study is the determination of blood concentration and the effectiveness of esketamine after nasal application.
Conditions Studied
Interventions
- •esketamine hydrochloride
Eligibility
Sex:MALE
Age:18 Years - 45 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria: * male * age ≥18 years ≤ 45 years * healthy * non-smoking * BMI 18-27 Exclusion Criteria: * abuse of drugs * known or supposed hypersensitivity and/or contraindication against ketamine or additives * participation of another clinical study within the last 30 days * chronic obstructed nose breathing or nasal polyps * dug allergy * blood donation within the last two months
Study Locations (1)
Clinical Research Center, University Hospital Basel
Basel, Canton of Basel-City, Switzerland